- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.03. | China's Ping An Insurance Ends Shanghai JV With Japanese Drugmaker Shionogi | 3 | Yicai Global | ||
| 18.02. | Shionogi gets approval in Japan for ADHD digital therapeutic | 3 | pharmaphorum | ||
| 05.02. | hVIVO reports positive results from Shionogi RSV trial | 8 | Sharecast | ||
| 05.02. | Shionogi's RSV antiviral shows promise in hVIVO trial | 4 | Investing.com | ||
| 05.02. | hVIVO PLC - Shionogi reports positive RSV trial results | 5 | RNS | ||
| 01.02. | Shionogi targets JPY550B revenue through QOL focus and global expansion | 2 | Seeking Alpha | ||
| SHIONOGI & CO LTD ADR Aktie jetzt für 0€ handeln | |||||
| 31.01. | Shionogi & Co. reports 9M results | 5 | Seeking Alpha | ||
| 30.01. | Shionogi's RSV antiviral reduces viral load in phase 2 trial of adults | 4 | FierceBiotech | ||
| 17.01. | Shionogi awarded $375m from HHS for preventative Covid-19 injectable | 2 | Pharmaceutical Technology | ||
| 19.12.24 | Nxera Pharma and Shionogi Launch QUVIVIQ in Japan for Adults with Insomnia | 14 | GlobeNewswire (USA) | ||
| 29.10.24 | Shionogi's Xocova effective in preventing symptomatic COVID-19: study | 7 | Seeking Alpha | ||
| 29.10.24 | Shionogi & Co. reports Q2 results | 9 | Seeking Alpha | ||
| 01.10.24 | Nxera Pharma Enters New Commercial Partnership with Shionogi for QUVIVIQ in Japan | 393 | GlobeNewswire (Europe) | QUVIVIQ is a potential best-in-class treatment in the high-growth, dual orexin antagonist class of medicines treating sleep disorders, such as insomnia Tokyo, Japan and Cambridge, UK, 1 October 2024... ► Artikel lesen | |
| 09.05.24 | Global Health Innovative Technology Fund (GHIT Fund): Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions | 1.312 | PR Newswire | TOKYO, May 9, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TRULIEVE CANNABIS | 4,310 | 0,00 % | Trulieve Aktie: Kann der Cannabis-Pionier die Wende schaffen? | US-Cannabiskonzern Trulieve kämpft mit Gewinneinbrüchen trotz Expansion. Kommende Quartalszahlen könnten Trendwende bringen oder Talfahrt beschleunigen. Absturz mit AnsageAnzeigeSollten Anleger sofort... ► Artikel lesen | |
| WEST PHARMACEUTICAL SERVICES | 186,75 | +1,00 % | West Pharmaceutical CFO Bernard Birkett To Step Down | WASHINGTON (dpa-AFX) - West Pharmaceutical Services, Inc. (WST), Thursday announced that the company's Chief Financial Officer Bernard Birkett has decided to step down from the position this... ► Artikel lesen | |
| KALA BIO | 2,820 | -2,76 % | KALA BIO, Inc.: KALA BIO Announces Chief Executive Officer Transition | ARLINGTON, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative... ► Artikel lesen | |
| SHIONOGI | 14,900 | 0,00 % | Dividendenbekanntmachungen (28.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC ADR US00108N1000 0,3716 USD 0,3442 EUR ACOM CO LTD JP3108600002 7 JPY 0,0429 EUR ADVANEX INC JP3213400009 20... ► Artikel lesen | |
| CHARLOTTES WEB | 0,084 | +12,08 % | Charlotte's Web Holdings, Inc.: Charlotte's Web Reports 2024 Fourth Quarter and Year-End Financial Results | 2024 Delivered Quarterly Growth and Large Scale Cost Optimization
LOUISVILLE, Colo., March 19, 2025 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF), Charlotte's... ► Artikel lesen | |
| BEXIMCO | 0,434 | 0,00 % | Dividendenbekanntmachungen (22.11.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ASSURED GUARANTY LTD BMG0585R1060 0,31 USD 0,2959 EUR BADGER METER INC US0565251081 0,34 USD 0,3245 EUR BANK CENTRAL ASIA TBK ADR US69368G1058 0... ► Artikel lesen | |
| LUYE PHARMA | 0,222 | 0,00 % | LUYE PHARMA (02186): VOLUNTARY ANNOUNCEMENT ROTIGOTINE LUYE TRANSDERMAL PATCH LAUNCHED IN THE UNITED KINGDOM | ||
| GUARDION HEALTH SCIENCES | 2,740 | 0,00 % | Guardion Health Sciences, Inc.: Guardion Health Sciences Announces Filing of Certificate of Dissolution | HOUSTON, TEXAS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) ("Guardion" or the "Company") today announced that it has filed a certificate of dissolution with the... ► Artikel lesen | |
| PERCHERON THERAPEUTICS | 0,008 | +33,33 % | PERCHERON THERAPEUTICS LIMITED: Results of General Meeting | ||
| MIRUM PHARMACEUTICALS | 35,000 | -1,69 % | Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates | FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today provided its preliminary and unaudited estimates for full-year 2024 net product sales, year-end cash balance... ► Artikel lesen | |
| AYURCANN | 0,009 | 0,00 % | Ayurcann Holdings Corp.: Ayurcann Reports Another Record Sales Growth In Q2 2025 Of $13,363,509 | Toronto, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) ("Ayurcann" or the "Company") is excited to announce record-breaking financial results for the... ► Artikel lesen | |
| AVANT BRANDS | 0,610 | -5,43 % | Avant Brands Inc.: Avant Brands Announces its Annual General and Special Meeting of Shareholders | KELOWNA, BC / ACCESS Newswire / April 22, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products... ► Artikel lesen | |
| EVEREST MEDICINES | 5,300 | +2,91 % | Everest Medicines Limited: Everest Medicines Announces Approval of 'B' Marker Removal from Company's Stock Code by the Hong Kong Stock Exchange | SHANGHAI, CHINA, Apr 22, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufacturing... ► Artikel lesen | |
| KALBE FARMA | 0,059 | -1,67 % | KLBF potentially distribute 45% to 55% dividend for 2024: KLBF has the potential to distribute 45% to ... | ||
| KOBAYASHI PHARMACEUTICAL | 32,600 | -0,61 % | Dividendenbekanntmachungen (27.12.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADWAYS INC JP3121970002 3 JPY 0,0182 EUR AGC INC JP3112000009 105 JPY 0,6373 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0... ► Artikel lesen |
Das Unternehmen SHIONOGI & CO LTD ADR kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 7,100 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHIONOGI & CO LTD ADR finden Sie auf Wallstreet Online.
